Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Callender

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat ReductionDerek H Jones, Jean Carruthers, John H Joseph, et al.
American Journal of Clinical Dermatology|July 3, 2019
Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic GroupsValerie D Callender, Andrew F Alexis, Linda F Stein Gold, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2025
Assessing Cutibacterium Acnes Susceptibility With Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel Use: Six-Month AnalysisMahmoud Ghannoum, Ahmed Eltokhy, James Sewake, et al.
Journal of Drugs in Dermatology : JDD|August 7, 2025
Safety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal AcneLeon H Kircik, Julie C Harper, Michael Gold, et al.
Journal of the American Academy of Dermatology|January 22, 2025
A call to action: The need to update population descriptors in dermatology research studies with the use of an inclusive skin classification systemValerie M Harvey, Stafford G Brown, Cheryl M Burgess, et al.
Journal of the American Academy of Dermatology|February 11, 2024
Integrating skin color assessments into clinical practice and research: A review of current approachesValerie M Harvey, Andrew Alexis, Chidubem A V Okeke, et al.
Dermatology and Therapy|May 9, 2024
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 AnalysisLeon H Kircik, Linda Stein Gold, Michael Gold, et al.
Journal of the American Academy of Dermatology|September 3, 2025
Beyond Fitzpatrick Skin Types: A Delphi Consensus on Key Considerations for a Universal Skin Typing ClassificationValerie D Callender, Andrew Alexis, Seemal R Desai, et al.
Archives of Dermatological Research|April 19, 2025
Rethinking the use of population descriptors in dermatology trials and beyond: disentangling race and ethnicity from skin colorValerie M Harvey, Jenna C Lester, Tarannum Jaleel, et al.
JAMA Dermatology|November 20, 2024
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus StatementYagiz Matthew Akiska, Paradi Mirmirani, Ingrid Roseborough, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat ReductionDerek H Jones, Jean Carruthers, John H Joseph, et al.
American Journal of Clinical Dermatology|July 3, 2019
Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic GroupsValerie D Callender, Andrew F Alexis, Linda F Stein Gold, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2025
Assessing Cutibacterium Acnes Susceptibility With Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel Use: Six-Month AnalysisMahmoud Ghannoum, Ahmed Eltokhy, James Sewake, et al.
Journal of Drugs in Dermatology : JDD|August 7, 2025
Safety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal AcneLeon H Kircik, Julie C Harper, Michael Gold, et al.
Journal of the American Academy of Dermatology|January 22, 2025
A call to action: The need to update population descriptors in dermatology research studies with the use of an inclusive skin classification systemValerie M Harvey, Stafford G Brown, Cheryl M Burgess, et al.
Journal of the American Academy of Dermatology|February 11, 2024
Integrating skin color assessments into clinical practice and research: A review of current approachesValerie M Harvey, Andrew Alexis, Chidubem A V Okeke, et al.
Dermatology and Therapy|May 9, 2024
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 AnalysisLeon H Kircik, Linda Stein Gold, Michael Gold, et al.
Journal of the American Academy of Dermatology|September 3, 2025
Beyond Fitzpatrick Skin Types: A Delphi Consensus on Key Considerations for a Universal Skin Typing ClassificationValerie D Callender, Andrew Alexis, Seemal R Desai, et al.
Archives of Dermatological Research|April 19, 2025
Rethinking the use of population descriptors in dermatology trials and beyond: disentangling race and ethnicity from skin colorValerie M Harvey, Jenna C Lester, Tarannum Jaleel, et al.
JAMA Dermatology|November 20, 2024
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus StatementYagiz Matthew Akiska, Paradi Mirmirani, Ingrid Roseborough, et al.
Pageof 10